MWNA
AVXL icon

Marshall Wace North America’s Anavex Life Sciences AVXL Stock Holding History

Marshall Wace North America’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-179,185
Closed -$2.68M – 1449
2021
Q1 		$2.68M Buy
+179,185
New +$1.96M 0.01% 734
2018
Q3 		– Sell
-12,050
Closed -$32K – 923
2018
Q2 		$32K Buy
+12,050
New +$33.7K ﹤0.01% 1339
2017
Q3 		– Sell
-35,141
Closed -$176K – 1250
2017
Q2 		$176K Buy
+35,141
New +$203K ﹤0.01% 1231

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return